These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1107354)

  • 1. Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1.
    Keusch GT; Jacewicz M; Levine MM; Hornick RB; Kochwa S
    J Clin Invest; 1976 Jan; 57(1):194-202. PubMed ID: 1107354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The humoral antibody response to Shigella dysenteriae type 1 infection, as determined by ELISA.
    Lindberg AA; Haeggman S; Karlsson K; Phung DC; Dang DT
    Bull World Health Organ; 1984; 62(4):597-606. PubMed ID: 6386207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of Shigella diarrhea. VI. Toxin and antitoxin in Shigella flexneri and Shigella sonnei infections in humans.
    Keusch GT; Jacewicz M
    J Infect Dis; 1977 Apr; 135(4):552-6. PubMed ID: 323376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
    Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M
    J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome.
    Ashkenazi S; Cleary TG; Lopez E; Pickering LK
    J Pediatr; 1988 Dec; 113(6):1008-14. PubMed ID: 3057156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live non-invasive Shigella dysenteriae 1 strain induces homologous protective immunity in a guinea pig colitis model.
    Barman S; Kumar R; Chowdhury G; Rani Saha D; Wajima T; Hamabata T; Ramamurthy T; Balakrish Nair G; Takeda Y; Koley H
    Microbiol Immunol; 2011 Oct; 55(10):683-93. PubMed ID: 21806676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with Shigella dysenteriae type 1: evaluation of antitoxic immunity in prevention of experimental disease in rhesus monkeys (Macaca mulatta).
    McIver J; Grady GF; Formal SB
    J Infect Dis; 1977 Sep; 136(3):416-21. PubMed ID: 409782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating antisomatic antibody response in Shiga dysentery & IgM & IgG activities after 2-mercaptoethanol treatment.
    Ahmed A; Aziz KM; Rahaman MM
    Indian J Med Res; 1984 Feb; 79():163-70. PubMed ID: 6378776
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response to outer membrane proteins in Shigella dysenteriae type 1 infection with special reference to appearance of murine antibodies.
    Chakrabarti S; Sinha AK
    Indian J Med Res; 1996 Jul; 104():142-7. PubMed ID: 8783518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of differentiation of antibodies to Shigella organisms according to the immunoglobulin class in the serological diagnostics of dysentery and in study of its epidemiology.
    Hasenson LB; Gennadeva TY; Lullu AV
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(3):298-307. PubMed ID: 4938457
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody response to lipopolysaccharide antigen in Shigella dysenteriae type 1 infection.
    Sinha AK; Bhattacharya SK; Saha MR; Bhattacharya MK; Sen D; Ghosh AC; Pal SC
    Indian J Med Res; 1988 Jul; 88():1-6. PubMed ID: 3053437
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial.
    Launay O; Sadorge C; Jolly N; Poirier B; Béchet S; van der Vliet D; Seffer V; Fenner N; Dowling K; Giemza R; Johnson J; Ndiaye A; Vray M; Sansonetti P; Morand P; Poyart C; Lewis D; Gougeon ML
    Vaccine; 2009 Feb; 27(8):1184-91. PubMed ID: 19135496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune processes in the course of infection with dysentery bacilli. IV. Transfer of immunity by means of fractions isolated from sera of mice immunized with dysentery bacilli.
    Wieczorek Z; Kowalewska D
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):357-65. PubMed ID: 7004396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga-like toxin production and attaching effacing activity of Escherichia coli associated with calf diarrhea.
    Mainil JG; Duchesnes CJ; Whipp SC; Marques LR; O'Brien AD; Casey TA; Moon HW
    Am J Vet Res; 1987 May; 48(5):743-8. PubMed ID: 3296889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune processes in the course of infection with dysentery bacilli. II. Transfer of immunity by means of serum.
    Wieczorek Z; Kowalewska D
    Arch Immunol Ther Exp (Warsz); 1976; 24(3):327-36. PubMed ID: 786210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of Shigella diarrhea. V. Relationship of shiga enterotoxin, neurotoxin, and cytotoxin.
    Keusch GT; Jacewicz M
    J Infect Dis; 1975 May; 131 Suppl():S33-9. PubMed ID: 236346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances.
    Munoz C; Baqar S; van de Verg L; Thupari J; Goldblum S; Olson JG; Taylor DN; Heresi GP; Murphy JR
    Am J Trop Med Hyg; 1995 Jul; 53(1):47-54. PubMed ID: 7542845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of rubella by demonstrating rubella-specific 19 S and 7 S antibodies (author's transl)].
    Dibbert HJ
    Zentralbl Bakteriol Orig A; 1976 Mar; 234(2):145-58. PubMed ID: 1274496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers.
    Sadorge C; Ndiaye A; Beveridge N; Frazer S; Giemza R; Jolly N; Johnson J; Liddy H; Cosgrove CA; Allavena P; Mantovani A; Béchet S; Fontaine-Thompson A; Griffin GE; Dupont F; Sansonetti PJ; Lewis DJ
    Vaccine; 2008 Feb; 26(7):978-87. PubMed ID: 18207287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.